Concepedia

Hongying Xiao

HX

Statistics

Publications

5

Citations

612

H-Index

5

Active since

2017

Affiliations

Tsinghua University(Current)

Center for Life Sciences

University of Illinois Urbana-Champaign

Sichuan University

Hubei University

Hongying Xiao is an author at Tsinghua University specializing in pharmacology, cell signaling, and cell biology.

ORCID

Publications per year

2017–2022

5

Publications

5

The Mevalonate Pathway Is a Druggable Target for Vaccine Adjuvant Discovery

Yun Xia, Yonghua Xie, Zhengsen Yu et al. · Cell · 2018 · 253 citations · Full text

, , +16

KRAS(G12D) can be targeted by potent inhibitors via formation of salt bridge

Zhongwei Mao, Hongying Xiao, Pan‐Pan Shen et al. · Cell Discovery · 2022 · 154 citations · Full text

, , +13

A Structural Change in Butyrophilin upon Phosphoantigen Binding Underlies Phosphoantigen-Mediated Vγ9Vδ2 T Cell Activation

Yunyun Yang, Liping Li, Linjie Yuan et al. · Immunity · 2019 · 132 citations · Full text

, , +12

Aberrant human ClpP activation disturbs mitochondrial proteome homeostasis to suppress pancreatic ductal adenocarcinoma

Pengyu Wang, Tao Zhang, Xinjing Wang et al. · Cell chemical biology · 2022 · 60 citations

, , +16

Combining Vγ9Vδ2 T Cells with a Lipophilic Bisphosphonate Efficiently Kills Activated Hepatic Stellate Cells

Xiaoying Zhou, Yanzheng Gu, Hongying Xiao et al. · Frontiers in Immunology · 2017 · 13 citations · Full text

, , +17

1–5 of 5